Promoter Acquires Shares in Beryl Drugs Ltd
A promoter has acquired a stake in Beryl Drugs Limited, bringing their holding up to nearly 1%.The acquisition details concern Mr. Sudhir Sethi, identified as a promoter, who purchased shares of Beryl Drugs Ltd. The transaction, which occurred on June 9, 2026, was conducted through market transactions.
Mr. Sudhir Sethi's acquisition raised his combined holding in the company to 9.91% w.r.t. total diluted share/voting capital after the said Acquisition. Prior to this transaction, his holding stood at 9.85%.
The financial details of the acquisition and the resulting shareholder structure are as follows:
| Metric | Before Acquisition (Mr. Sudhir Sethi) | After Acquisition (Mr. Sudhir Sethi) |
|---|---|---|
| Shares Carrying Voting Rights Held | 500,657 | 504,139 |
| Percentage Holding (w.r.t. Total) | 9.85% | 9.91% |
| Mode of Acquisition | Market Transactions | Market Transactions |
| Shares Acquired in this Transaction | 3,482 | N/A |
The transaction represents a change in holding for Mr. Sudhir Sethi, a promoter, who is among multiple promoters listed associated with Beryl Drugs Ltd. The company's total diluted share/voting capital remained at 50,71,700 after the acquisition.
Stock Price Movement
As of 10:24, Beryl Drugs Ltd shares are edging higher in the market, currently trading at ₹25.16, which represents a strong 3.75% gain. The stock moved throughout the morning session, establishing an intraday low at ₹25.16 before touching an intraday high of ₹25.30.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.